|
| |
| | | 65920 | | 06.06.2016 | | Bristol-Myers Squibb SA | | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Empliciti 300 mg | Pulver zur Herstellung einer Infusionslösung | Lyophilisate (Elotuzumabum 300 mg) | L01XC23 | | | 02 | Empliciti 400 mg | Pulver zur Herstellung einer Infusionslösung | Lyophilisate (Elotuzumabum 400 mg) | L01XC23 | |
|
|
|
